Indaptus Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Income	-15.42	-14.32	-7.71	-3.58	-47.6	-43.54	-28.91	-13.36	-7.18	-6.5	Upgrade
Depreciation & Amortization	0	0	0	0	0.85	0.86	0.83	0	0	0	Upgrade
Share-Based Compensation	2.97	2.96	1.51	0.14	3.22	3.23	1.2	0	0	0	Upgrade
Other Operating Activities	-0.95	-1.71	-5.09	0.12	14.48	0.38	4.75	1.36	-0.75	1.75	Upgrade
Operating Cash Flow	-13.41	-13.08	-11.29	-3.32	-29.05	-39.08	-22.13	-12.01	-7.93	-4.75	Upgrade
Capital Expenditures	0	0.17	0.45	0	-0.92	-4.67	-4.99	-0.48	-1.38	-0.08	Upgrade
Change in Investments	17.14	-16.6	0	0	0.58	0.3	0.25	5.21	-4.99	2.86	Upgrade
Other Investing Activities	-	-	-	-	-2.87	-4.93	-	-	-	-	Upgrade
Investing Cash Flow	17.14	-16.43	0.45	0	-3.21	-9.3	-4.75	4.72	-6.37	2.78	Upgrade
Share Issuance / Repurchase	0	0	30.34	0	2.37	35.06	63.71	0	30.61	4.68	Upgrade
Debt Issued / Paid	0	0	5	1.16	0	0	0	0	0	0	Upgrade
Other Financing Activities	-	-	13	-	-	-	-	-	1.84	-	Upgrade
Financing Cash Flow	0	0	48.34	1.16	2.37	35.06	63.71	0	32.45	4.68	Upgrade
Exchange Rate Effect	0	0	0	0	-0.07	-0.83	0.13	0.01	-0.23	-0.37	Upgrade
Net Cash Flow	3.74	-29.51	37.49	-2.16	-29.89	-13.32	36.83	-7.28	18.15	2.71	Upgrade
Free Cash Flow	-13.41	-12.91	-10.84	-3.32	-29.97	-43.74	-27.13	-12.49	-9.32	-4.83	Upgrade
Free Cash Flow Per Share	-1.60	-1.56	-2.65	-1.71	-70.97	-112.19	-122.88	-87.26	-73.71	-38.20	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).